Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Trial to Assess Consumer Self-Selection and Use of Gabapentin for Occasional Sleeplessness in an Over-the-Counter Environment

ClinicalTrials.gov ID: NCT00659100

Public ClinicalTrials.gov record NCT00659100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 4:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 3-Month, Open-Label, Pharmacy-Based, Actual-Use Trial in a Simulated Over-The-Counter (OTC) Environment to Assess Self-Selection and Consumer Use Patterns of Gabapentin 250 mg for Occasional Sleeplessness

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess consumers' behaviors related to gabapentin self- selection and use, relative to warnings and directions for use, as described in the proposed over-the-counter (OTC) product label.

Study identification

NCT ID
NCT00659100
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
1,254 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2006 (Type not available)
Primary completion
Not listed
Completion
Jan 2007 (Actual)
Last update posted
Feb 2, 2021

2006 – 2007

United States locations

U.S. sites
35
U.S. states
11
U.S. cities
32
Facility City State ZIP Site status
Pfizer Investigational Site Anaheim California 92801 —
Pfizer Investigational Site Bonita California 91902 —
Pfizer Investigational Site Fallbrook California 92028 —
Pfizer Investigational Site Hacienda Heights California 91746 —
Pfizer Investigational Site La Mesa California 91942 —
Pfizer Investigational Site Oceanside California 92054 —
Pfizer Investigational Site Orange California 92866 —
Pfizer Investigational Site San Dimas California 91773 —
Pfizer Investigational Site Pembroke Pines Florida 33026 —
Pfizer Investigational Site Weston Florida 33326 —
Pfizer Investigational Site Baltimore Maryland 21228 —
Pfizer Investigational Site Elk River Minnesota 55330 —
Pfizer Investigational Site Northfield Minnesota 55057 —
Pfizer Investigational Site Red Wing Minnesota 55066 —
Pfizer Investigational Site Saint Louis Park Minnesota 55426 —
Pfizer Investigational Site Holly Springs Mississippi 38625 —
Pfizer Investigational Site Belton Missouri 64012 —
Pfizer Investigational Site Independence Missouri 64054 —
Pfizer Investigational Site Albuquerque New Mexico 87104 —
Pfizer Investigational Site Albuquerque New Mexico 87110 —
Pfizer Investigational Site Taos New Mexico 87571 —
Pfizer Investigational Site Cary North Carolina 27513 —
Pfizer Investigational Site Chapel Hill North Carolina 27514 —
Pfizer Investigational Site Raleigh North Carolina 27606 —
Pfizer Investigational Site Raleigh North Carolina 27609 —
Pfizer Investigational Site Raleigh North Carolina 27612 —
Pfizer Investigational Site Houston Texas 77088 —
Pfizer Investigational Site Pearland Texas 77581 —
Pfizer Investigational Site Bountiful Utah 84010 —
Pfizer Investigational Site Ogden Utah 84401 —
Pfizer Investigational Site Salt Lake City Utah 84121 —
Pfizer Investigational Site Syracuse Utah 84075 —
Pfizer Investigational Site West Valley City Utah 84120 —
Pfizer Investigational Site Falls Church Virginia 22041 —
Pfizer Investigational Site Richmond Virginia 23233 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00659100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 2, 2021 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00659100 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →